Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

The recent selloff has GreensKeeper excited about the price declines. Click here to read on to learn about our response to ...

The Gairdner Foundation is pleased to announce the 2025 Canada Gairdner Award laureates, recognizing some of the world's most significant biomedical and global health research and discoveries.

With the latest approval, Vertex's Kaftrio is now eligible to treat about 4,000 people living in the EU with rare mutations ...

Its market leadership should be strengthened by the recent U.S. Food and Drug Administration (FDA) approval of Alyftrek. This new CF offers a more convenient dosing than Vertex's top-selling ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...